The efficacy of anti‐angiogenic drugs in gastric‐type endocervical adenocarcinoma: A retrospective study
We firstly evaluated the efficacy of anti-angiogenic drugs in treating patients with GEA. Although with a small sample size, our preliminary results clearly proposed that the anti-angiogenic therapy failed in suppressing tumors and should not be a preferred choice for GEA. As a much rarer tumor without standard treatments, we herein warned of a pitfall for gynecologic oncologists when facing this malignancy.
Authors
- Qing Duan (ORCID: https://orcid.org/0000-0001-5815-7797)
- Ning Su
- Xiufang Li (ORCID: https://orcid.org/0000-0002-6404-5916)
- Haifeng Qiu
- Dian Wang (ORCID: https://orcid.org/0000-0002-9346-0588)
- Jing Li (ORCID: https://orcid.org/0009-0003-6354-6975)
Institutions
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Anyang Tumor Hospital (CN)
Publication Details
- Journal
- Journal of obstetrics and gynaecology research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/jog.16247
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00